# EDGAR Filing Document

**Accession Number:** 0000010456
**File Stem:** 0001628280-25-053248
**Filing Date:** 2025-11
**Character Count:** 9317
**Document Hash:** 03d7b045cd75dc8523812d9a27dd12b9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-25-053248.hdr.sgml**: 20251119

**ACCESSION NUMBER**: 0001628280-25-053248

**CONFORMED SUBMISSION TYPE**: FWP

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20251119

**DATE AS OF CHANGE**: 20251119

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BAXTER INTERNATIONAL INC
- **CENTRAL INDEX KEY:** 0000010456
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 360781620
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** FWP
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 333-285217
- **FILM NUMBER:** 251500223

**BUSINESS ADDRESS:**
- **STREET 1:** ONE BAXTER PARKWAY
- **CITY:** DEERFIELD
- **STATE:** IL
- **ZIP:** 60015
- **BUSINESS PHONE:** 2249482000

**MAIL ADDRESS:**
- **STREET 1:** ONE BAXTER PARKWAY
- **CITY:** DEERFIELD
- **STATE:** IL
- **ZIP:** 60015

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BAXTER TRAVENOL LABORATORIES INC
- **DATE OF NAME CHANGE:** 19880522

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BAXTER LABORATORIES INC
- **DATE OF NAME CHANGE:** 19760608
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BAXTER INTERNATIONAL INC
- **CENTRAL INDEX KEY:** 0000010456
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 360781620
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** FWP

**BUSINESS ADDRESS:**
- **STREET 1:** ONE BAXTER PARKWAY
- **CITY:** DEERFIELD
- **STATE:** IL
- **ZIP:** 60015
- **BUSINESS PHONE:** 2249482000

**MAIL ADDRESS:**
- **STREET 1:** ONE BAXTER PARKWAY
- **CITY:** DEERFIELD
- **STATE:** IL
- **ZIP:** 60015

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BAXTER TRAVENOL LABORATORIES INC
- **DATE OF NAME CHANGE:** 19880522

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BAXTER LABORATORIES INC
- **DATE OF NAME CHANGE:** 19760608

**Filed Pursuant to Rule 433**

**Free Writing Prospectus dated November 19, 2025**

**Relating to Preliminary Prospectus dated November 19, 2025**

**Registration Statement No. 333-285217**

![baxterlogoa.jpg](baxterlogoa.jpg)

**PRICING TERM SHEET** 

---

| | |
|:---|:---|
| Issuer: | Baxter International Inc. |
| Title of Designated Securities:  | 4.450% Senior Notes due 2029 (the "2029 Notes")<br>4.900% Senior Notes due 2030 (the "2030 Notes")<br>5.650% Senior Notes due 2035 (the "2035 Notes") |
| Ratings (Moody's / S&P)\*: | Baa3 (stable) / BBB- (stable) |
| Format: | SEC Registered |
| Ranking: | 2029 Notes: Senior unsecured<br>2030 Notes: Senior unsecured<br>2035 Notes: Senior unsecured |
| Offering Size: | 2029 Notes: $300,000,000<br>2030 Notes: $700,000,000<br>2035 Notes: $1,000,000,000 |
| Trade Date: | November 19, 2025 |
| Settlement Date\*\*: | December 4, 2025 (T+10)  |
| Maturity Date: | 2029 Notes: February 15, 2029<br>2030 Notes: December 15, 2030<br>2035 Notes: December 15, 2035 |
| Interest Rate: | 2029 Notes: 4.450%<br>2030 Notes: 4.900%<br>2035 Notes: 5.650% |
| Interest Rate Adjustment: | The interest rate payable on each series of the Notes may be increased if either Moody's Investors Service, Inc. ("Moody's") or S&P Global Ratings ("S&P") (or, in each case, a substitute rating agency therefor), downgrades the debt rating applicable to such Notes. |
| Issue Price to Public:  | 2029 Notes: 99.932% of the principal amount<br>2030 Notes: 99.826% of the principal amount<br>2035 Notes: 99.899% of the principal amount<br>In each case, plus accrued interest, if any, from December 4, 2025 |

---

------

---

| | |
|:---|:---|
| Interest Payment Dates: | 2029 Notes: Semi-annually on each February 15 and August 15, commencing on February 15, 2026<br>2030 Notes: Semi-annually on each June 15 and December 15, commencing on June 15, 2026<br>2035 Notes: Semi-annually on each June 15 and December 15, commencing on June 15, 2026 |
| Benchmark Treasury: | 2029 Notes: 3.500% UST due November 15, 2028<br>2030 Notes: 3.625% UST due October 31, 2030<br>2035 Notes: 4.000% UST due November 15, 2035 |
| Benchmark Treasury Price / Yield: | 2029 Notes: 99-25 ¼ / 3.575%<br>2030 Notes: 99-22 ¾ / 3.689%<br>2035 Notes: 99-02 <sup>+</sup> / 4.113% |
| Spread to Benchmark Treasury: | 2029 Notes: +90 bps<br>2030 Notes: +125 bps<br>2035 Notes: +155 bps  |
| Yield to Maturity: | 2029 Notes: 4.475%<br>2030 Notes: 4.939%<br>2035 Notes: 5.663% |
| Day Count Basis: | 30/360 |
| Optional Redemption: | 2029 Notes: Following issuance and prior to January 15, 2029, make-whole +15 bps. At any time on or after January 15, 2029, par call<br>2030 Notes: Following issuance and prior to November 15, 2030, make-whole +20 bps. At any time on or after November 15, 2030, par call<br>2035 Notes: Following issuance and prior to September 15, 2035, make-whole +25 bps. At any time on or after September 15, 2035, par call |
| Minimum Denomination: | $2,000 x $1,000 |
| CUSIP / ISIN: | 2029 Notes: 071813 DC0 / US071813DC01<br>2030 Notes: 071813 DD8 / US071813DD83<br>2035 Notes: 071813 DE6 / US071813DE66 |
| Settlement and Trading: | Through the facilities of The Depository Trust Company |
| Governing Law: | New York Law |
| Joint Book-Running Managers: | Citigroup Global Markets Inc. <br>BofA Securities, Inc.<br>J.P. Morgan Securities LLC <br>Deutsche Bank Securities Inc.<br>Goldman Sachs & Co. LLC<br>Morgan Stanley & Co. LLC  |

---

------

---

| | |
|:---|:---|
| Co-Managers:  | HSBC Securities (USA) Inc.<br>Mizuho Securities USA LLC<br>Scotia Capital (USA) Inc.<br>SG Americas Securities, LLC<br>TD Securities (USA) LLC<br>U.S. Bancorp Investments, Inc.<br>Wells Fargo Securities, LLC<br>Academy Securities, Inc.<br>Independence Point Securities LLC<br>Loop Capital Markets LLC<br>MUFG Securities Americas Inc.<br>R. Seelaus & Co., LLC |

---

**\* Note**: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.

\*\* Under Rule 15c6-1 of the U.S. Securities Exchange Act of 1934, as amended, trades in the secondary market generally are required to settle in one business day, unless the parties to a trade expressly agree otherwise. Accordingly, purchasers who wish to trade the Notes prior to the business day immediately before the Settlement Date will be required, by virtue of the fact that the Notes initially settle in T+10, to specify alternative settlement arrangements at the time of any such trade to prevent a failed settlement.

**Changes from Preliminary Prospectus Supplement**

*The Preliminary Prospectus Supplement is hereby updated to reflect the following changes:*

The Company expects to increase the Maximum Cash Spent in the Concurrent 2027 Notes Tender Offer from $300 million to $600 million and use the additional net proceeds to repurchase any 2027 Notes validly tendered and not validly withdrawn.

Nothing herein should be construed as an offer to purchase or a solicitation of an offer to purchase any of the Company's 2027 Notes. The Concurrent 2027 Notes Tender Offer is being made only upon the terms and conditions set forth in the Offer to Purchase.

***The Issuer has filed a registration statement (including a prospectus) and a preliminary prospectus supplement with the U.S. Securities and Exchange Commission ("SEC") for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the Issuer has filed with the SEC for more complete information about the Issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the Issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it. In the case of Citigroup Global Markets Inc., you may request the prospectus by contacting Citigroup Global Markets Inc. toll-free at 1-800-831-9146; in the case of BofA Securities, Inc., you may request the prospectus by contacting BofA Securities, Inc. toll-free at 1-800-294-1322; in the case of J.P. Morgan Securities LLC, you may request the prospectus by contacting J.P. Morgan Securities LLC collect at 1-212-834-4533.***

***The information in this pricing term sheet supplements the preliminary prospectus supplement and the accompanying prospectus, and supersedes the information in the preliminary prospectus supplement and the accompanying prospectus to the extent it is inconsistent with the information in such preliminary prospectus supplement or the accompanying prospectus.***

***No PRIIPs key information document (KID) has been prepared as the securities described in this document are not intended to and should not be offered, sold or otherwise made available to any retail investor in the European Economic Area.***

------

***Any disclaimers or other notices that may appear below are not applicable to this communication and should be disregarded. Such disclaimers or other notices were automatically generated as a result of this communication being sent via Bloomberg or another email system.***